Skip to main content

Table 2 Differential miRNA expression between non-metastatic and metastatic OSCC samples

From: Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma

 

Fold change (N0/N+)

P value

hsa-mir-31-5p

3.33

2.02E-002

hsa-mir-130b-5p

3.04

3.14E-002

hsa-mir-301a-3p

2.29

1.06E-001

hsa-mir-1301

−2.07

1.89E-001

hsa-mir-551b-3p

−2.10

1.60E-001

hsa-mir-345-5p

−2.22

1.37E-001

hsa-mir-30a-5p

−2.31

1.25E-001

hsa-mir-326

−2.32

1.18E-001

hsa-mir-769-5p

−2.35

1.13E-001

hsa-mir-139-5p

−2.40

1.02E-001

hsa-mir-218-5p

−2.72

6.69E-002

hsa-mir-106a-5p

−2.81

8.02E-002

hsa-mir-335-5p

−3.56

2.16E-002

hsa-mir-296-5p

−3.58

2.21E-002

hsa-mir-20b-5p

−3.88

1.54E-002

hsa-mir-23c

−4.98

4.83E-003

hsa-mir-1277-3p

−9.82

1.80E-004

hsa-mir-181d-5p

−10.01

1.66E-004

  1. Positive Fold Change: higher expression in non-metastasized OSCC; negative Fold Change: higher expression in metastasized OSCC. p-values were adjusted using the False Discovery Rate (FDR) correction and adjusted p values < 0.05 are in bold in order to highlight statistical significance. The suffix 3p/5p indicate which of the two arms of the miRNA was considered in the analysis, being either exclusively expressed or predominantly expressed in the dataset (Additional files 2 and 3 present detailed information on the expression levels of each arm)